DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway
出版年份 2022 全文链接
标题
DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway
作者
关键词
-
出版物
EBioMedicine
Volume 81, Issue -, Pages 104100
出版商
Elsevier BV
发表日期
2022-06-08
DOI
10.1016/j.ebiom.2022.104100
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression
- (2022) Dongming Lv et al. ONCOGENE
- UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex
- (2021) Jalila Chagraoui et al. Cell Stem Cell
- Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
- (2021) Yu-Pei Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target
- (2021) Chun Cheng et al. Cell Death & Disease
- Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
- (2021) Yi Que et al. Journal for ImmunoTherapy of Cancer
- Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling
- (2021) Bas Ponsioen et al. NATURE CELL BIOLOGY
- Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade
- (2021) Kun Tu et al. ACS Applied Materials & Interfaces
- Collective ERK/Akt activity waves orchestrate epithelial homeostasis by driving apoptosis-induced survival
- (2021) Paolo Armando Gagliardi et al. DEVELOPMENTAL CELL
- Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
- (2021) Shaodong Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Yunpeng Yang et al. LANCET ONCOLOGY
- Suppression of Extracellular Vesicle VEGF-C–mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor
- (2021) Chu-An Wang et al. MOLECULAR CANCER THERAPEUTICS
- TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination
- (2021) Guixin Zhu et al. NATURE CELL BIOLOGY
- Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
- (2021) Hai-Qiang Mai et al. NATURE MEDICINE
- Nasopharyngeal carcinoma: an evolving paradigm
- (2021) Kenneth C. W. Wong et al. Nature Reviews Clinical Oncology
- HDAC1 is required for GATA-1 transcription activity, global chromatin occupancy and hematopoiesis
- (2021) Bowen Yan et al. NUCLEIC ACIDS RESEARCH
- EBF3 reactivation by inhibiting the EGR1/EZH2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma
- (2021) Shirong Ding et al. CANCER LETTERS
- Structural dynamics in the evolution of a bilobed protein scaffold
- (2021) Giorgos Gouridis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inner nuclear protein Matrin-3 coordinates cell differentiation by stabilizing chromatin architecture
- (2021) Hye Ji Cha et al. Nature Communications
- The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth
- (2020) Baisakhi Mondal et al. eLife
- Microbiota-derived metabolite promotes HDAC3 activity in the gut
- (2020) Shu-en Wu et al. NATURE
- Chemoradiotherapy improves NPC outcomes
- (2020) Peter Sidaway Nature Reviews Clinical Oncology
- The MiDAC histone deacetylase complex is essential for embryonic development and has a unique multivalent structure
- (2020) Robert E. Turnbull et al. Nature Communications
- A distal regulatory region of a class I human histone deacetylase
- (2020) Nicolas D. Werbeck et al. Nature Communications
- Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway
- (2020) Hao Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Anti-Tumor T-cell Immunity
- (2020) Aayoung Hong et al. Cancer Discovery
- Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Zefei Jiang et al. LANCET ONCOLOGY
- Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa
- (2019) Cheng-Long Huang et al. EUROPEAN RADIOLOGY
- Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer
- (2018) Yuki Sawai et al. LABORATORY INVESTIGATION
- Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
- (2016) Li Zhang et al. LANCET
- Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
- (2015) Y. Shi et al. ANNALS OF ONCOLOGY
- Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
- (2015) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Structural and functional characterization of a cell cycle associated HDAC1/2 complex reveals the structural basis for complex assembly and nucleosome targeting
- (2015) Toshimasa Itoh et al. NUCLEIC ACIDS RESEARCH
- Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism
- (2014) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts
- (2014) Mélanie Gressette et al. PLoS One
- Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
- (2012) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Quantitative Proteomics Reveals the Basis for the Biochemical Specificity of the Cell-Cycle Machinery
- (2011) Felicia Walton Pagliuca et al. MOLECULAR CELL
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- TdT interacting factor 1 enhances TdT ubiquitylation through recruitment of BPOZ-2 into nucleus from cytoplasm
- (2009) Takahide Hayano et al. GENES TO CELLS
- Dual-specificity MAP kinase phosphatases (MKPs) and cancer
- (2008) Stephen M. Keyse CANCER AND METASTASIS REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started